Today, we had the great honor of welcoming President Barack Obama to the campus of the National Institutes of Health (NIH) in Bethesda, MD—to see first-hand the progress that biomedical research is making against Ebola virus disease. The President toured the NIH Vaccine Research Center, and met with scientists who are working hard to develop ways to combat this deadly virus that continues to devastate West Africa. And, in a speech before a packed auditorium at the NIH Clinical Center, the President praised the contributions of NIH staff. He also emphasized the need for emergency Congressional authorization of resources to ensure that our nation’s research and public health efforts against Ebola will lead as quickly as possible to an end to this devastating outbreak.
The President heard about many encouraging advances against Ebola during his visit here, and I’d like to share a couple with you now. I think these examples—one about a vaccine and one about a treatment—speak to the extraordinary ways in which scientists from different fields, disciplines, and organizations are pulling together to tackle this urgent disease threat.
The first piece of good news relates to efforts to prevent Ebola virus disease: we recently received promising, early results from the initial clinical trial of a candidate Ebola vaccine, conducted here at the NIH Clinical Center. In a study published last week in The New England Journal of Medicine, researchers reported that this Phase I trial established that the vaccine was well tolerated—and that it produced measurable immune responses—in all 20 healthy adult volunteers who received it.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.